⌘K

Login Start Free

Home/Filings/4/0001104659-25-107423

4//SEC Filing

BENTSUR RON 4

Accession 0001104659-25-107423

CIK 0001875558other

View on SEC.gov Company Profile

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 8:01 AM ET

Size

4.7 KB

Accession

0001104659-25-107423

Insider Transaction Report

Form 4

Period: 2025-11-05

Nuvectis Pharma, Inc.NVCT

DirectorChairman & CEO10% Owner

Transactions

Purchase
Common Stock
2025-11-05$5.72/sh+5,000$28,600→ 3,525,924 total

Footnotes (1)

[F1]Includes 676,759 shares of restricted stock.

Documents

1 file

4
tm2530379-3_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Nuvectis Pharma, Inc.

CIK 0001875558

Entity typeother

Related Parties

1

filerCIK 0001251213

Filing Metadata

Form type: 4
Filed: Nov 5, 7:00 PM ET
Accepted: Nov 6, 8:01 AM ET
Size: 4.7 KB

View on SEC.gov